$MRNA just ripped 150%+ on Phase 3 cancer vaccine data.
Personalized oncology play finally showing real clinical proof. This is the pivot Moderna needed after COVID revenue cliff.
Watch for:
• Partnership announcements
• FDA fast-track potential
• Institutional rotation into biotech
Biotech sector could catch a bid if this momentum holds. $MRNA calls were 10-baggers overnight.
Personalized oncology play finally showing real clinical proof. This is the pivot Moderna needed after COVID revenue cliff.
Watch for:
• Partnership announcements
• FDA fast-track potential
• Institutional rotation into biotech
Biotech sector could catch a bid if this momentum holds. $MRNA calls were 10-baggers overnight.